MHC structure and autoimmune T cell repertoire development

Current Opinion in Immunology

Volumn 11, Issue 6, 1999, Pages 638-642

  Ridgway, William M ^a   Fathman, C Garrison ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; AUTOIMMUNE DISEASE; CELL SELECTION; DIABETES MELLITUS; DISEASE PREDISPOSITION; HUMAN; NONHUMAN; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE; THYMUS; TRANSGENE;

EID: 0032707791     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00030-8     Document Type: Review

References (46)

1. Sebzda E., Mariathasan S., Ohteki T., Jones R., Bachmann M.F., Ohashi P.S. Selection of the T cell repertoire. Annu Rev Immunol. 17:1999;829-874.
2. Benoist C., Mathis D. Positive selection of T cells: fastidious or promiscuous? Curr Opin Immunol. 9:1997;245-249.
3. Jameson S.C., Bevan M.J. T-cell selection. Curr Opin Immunol. 10:1998;214-219.
4. Marrack P., Kappler J. Positive selection of thymocytes bearing alpha beta T cell receptors. Curr Opin Immunol. 9:1997;250-255.
5. Acha-Orbea H., McDevitt H.O. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc Natl Acad Sci USA. 84:1987;2435-2439.
6. Todd J.A., Bell J.I., McDevitt H.O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 329:1987;599-604.
7. Wicker L.S., Miller B.J., Coker L.Z., McNally S.E., Scott S., Mullen Y., Appel M.C. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med. 165:1987;1639-1654.
8. Slattery R.M., Kjer-Nielsen L., Allison J., Charlton B., Mandel T.E., Miller J.F. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature. 345:1990;724-726.
9. Lund T., O'Reilly L., Hutchings P., Kanagawa O., Simpson E., Gravely R., Chandler P., Dyson J., Picard J.K., Edwards A.et al. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature. 345:1990;727-729.
10. Bohme J., Schuhbaur B., Kanagawa O., Benoist C., Mathis D. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science. 249:1990;293-295.
11. Vaysburd M., Lock C., McDevitt H. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides. J Exp Med. 182:1995;897-902.
12. Wucherpfennig K.W., Strominger J.L. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med. 181:1995;1597-1601.
13. Fairchild P.J., Wildgoose R., Atherton E., Webb S., Wraith D.C. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int Immunol. 5:1993;1151-1158.
14. Liu G.Y., Fairchild P.J., Smith R.M., Prowle J.R., Kioussis D., Wraith D.C. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 3:1995;407-415.
15. Carrasco-Marin E., Shimizu J., Kanagawa O., Unanue E.R. The class II MHC IAg7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol. 156:1996;450-458.
16. Reizis B., Eisenstein M., Bockova J., Konen-Waisman S., Mor F., Elias D., Cohen I.R. Molecular characterization of the diabetes-associated mouse MHC class II and protein IAg7. Int Immunol. 9:1997;43-51.
17. Peterson M., Sant A.J. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM. J Immunol. 161:1998;2961-2967.
18. g7 molecules are increased on antigen-presenting cells of NOD mice.
19. Reich E.P., von Grafenstein H., Barlow A., Swenson K.E., Williams K., Janeway C.A. Jr. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J Immunol. 152:1994;2279-2288.
20. Ridgway W.M., Ito H., Fasso M., Yu C., Fathman C.G. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. J Exp Med. 188:1998;2267-2275. By using NOD mice, NOD-MHC transgenics, NOD-MHC congenics, NOD-MHC knockouts and various F1 mice, the authors study the effect of variable MHC expression on NOD autoreactive T cell responses. The results suggest an explanation for the MHC homozygosity requirement in autoimmune diabetes and support the theory that the disease-associated MHC molecules mediate defective thymic selection.
21. Ridgway W.M., Fasso M., Lanctot A., Garvey C., Fathman C.G. Breaking self-tolerance in nonobese diabetic mice. J Exp Med. 183:1996;1657-1662.
22. Kanagawa O., Martin S.M., Vaupel B.A., Carrasco-Marin E., Unanue E.R. Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. Proc Natl Acad Sci USA. 95:1998;1721-1724.
23. Schmidt D., Verdaguer J., Averill N., Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med. 186:1997;1059-1075.
24. Schmidt D., Amrani A., Verdaguer J., Bou S., Santamaria P. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules. J Immunol. 162:1999;4627-4636.
25. Nepom G.T., Kwok W.W. Molecular basis for HLA-DQ associations with IDDM. Diabetes. 47:1998;1177-1184. An excellent review of several years' work on the structure and function of disease-associated MHC molecules in human diabetes, supporting the theory that the MHC biases the peripheral T cell repertoire towards autoimmunity.
26. Buckner J., Kwok W.W., Nepom B., Nepom G.T. Modulation of HLA-DQ and binding properties by differences in class II dimer stability and pH-dependent peptide interactions. J Immunol. 157:1996;4940-4945.
27. Ettinger R.A., Liu A.W., Nepom G.T., Kwok W.W. Exceptional stability of the HLA-DQA1*/DQB1*0602 alpha beta protein dimer, the class II MHC molecule associated with protection from insulin-dependent diabetes mellitus. J Immunol 1998. 161:0102;6439-6445.
28. Boyton R.J., Lohmann T., Londei M., Kalbacher H., Halder T., Frater A.J., Douek D.C., Leslie D.G., Flavell R.A., Altmann D.M. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice. Int Immunol. 10:1998;1765-1776. The authors study GAD responses in human twins discordant for diabetes and also study DQ8-transgenic mice; results show that disease-associated GAD peptides bind DQB1*0302 with low affinity. The results fit a model of defective thymic selection by poor-binding autoantigens.
29. Laufer T.M., DeKoning J., Markowitz J.S., Lo D., Glimcher L.H. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature. 383:1996;81-85.
30. Fung-Leung W.P., Surh C.D., Liljedahl M., Pang J., Leturcq D., Peterson P.A., Webb S.R., Karlsson L. Antigen presentation and T cell development in H2-M-deficient mice. Science. 271:1996;1278-1281.
31. Martin W.D., Hicks G.G., Mendiratta S.K., Leva H.I., Ruley H.E., Van Kaer L. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell. 84:1996;543-550.
32. Miyazaki T., Wolf P., Tourne S., Waltzinger C., Dierich A., Barois N., Ploegh H., Benoist C., Mathis D. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell. 84:1996;531-541.
33. Ignatowicz L., Kappler J., Marrack P. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell. 84:1996;521-529.
34. Fukui Y., Ishimoto T., Utsuyama M., Gyotoku T., Koga T., Nakao K., Hirokawa K., Katsuki M., Sasazuki T. Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. Immunity. 6:1997;401-410.
35. Wu A.Y., Schulman S.J., Marconi L.A., Reilly C.R., Scott B., Lo D. Protection against diabetes by MHC heterozygosity and reversal by cyclophosphamide. Cell Immunol. 184:1998;112-120.
36. Balasa B., Lee J., Sarvetnick N. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice. Cell Immunol. 193:1999;170-178.
37. Ridgway W.M., Fathman C.G. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes. Clin Immunol Immunopathol. 86:1998;3-10.
38. g7 necessitates a correlative increase in mean population TCR affinity for self-antigen to attain selection thresholds. The increase in mean population TCR affinity results in escape from negative selection of T cells which ordinarily would be deleted, predisposing the repertoire to peripheral autoimmunity.
39. Ashton-Rickardt P.G., Tonegawa S. A differential avidity model for T cell selection. Immunol Today. 15:1994;362-366.
40. Ashton-Rickardt P.G., Bandeira A., Delaney J.R., Van Kaer L., Pircher H.P., Zinkernagel R.M., Tonegawa S. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 76:1994;651-663.
41. Kim D.T., Rothbard J.B., Bloom D.D., Fathman C.G. Quantitative analysis of T cell activation: role of TCR/ligand density and TCR affinity. J Immunol. 156:1996;2737-2742.
42. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., Malissen B., Zinkernagel R.M., Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:1991;305-317.
43. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev. 14:1998;129-151.
44. Constant S., Pfeiffer C., Woodard A., Pasqualini T., Bottomly K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med. 182:1995;1591-1596.
45. Hosken N.A., Shibuya K., Heath A.W., Murphy K.M., O'Garra A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med. 182:1995;1579-1584.
46. Wicker L.S., Todd J.A., Peterson L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol. 13:1995;179-200.